Figure 2: Categorical weight loss of either 5%, 10%, or 15% in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Improvement measures: Neutralizing agents can be combined to eliminate the interference of antibacterial components, or membrane filtration can be adopted to enhance sensitivity
Before using any peptide in a research model, consult the relevant institutional review board, animal-care committee, and biosafety office
Free from parabens, phthalates, fragrances, and artificial colors, with a fast-absorbing, non-greasy formula
This peptide is commonly incorporated into copper peptide serums and peptide creams for topical application
5 neighboring loop also included